A. Bouzaglou

Buserelin as primary therapy in advanced prostatic carcinoma

C. Presant, C. Wiseman, M. Soloway, 1985 .

Solitary Brain Metastasis: Results of an RTOG/SWOG Protocol Evaluation Surgery + RT versus RT Alone

J. Crowley, W. Sause, M. Rotman, 1990, American journal of clinical oncology.

Pilot phase II trial of amphotericin B and CCNU in renal and colorectal carcinomas.

C. Presant, C. Wiseman, P. Kennedy, 1986, European journal of cancer & clinical oncology.

Verapamil Reversal of Clinical Doxorubicin Resistance in Human Cancer A Wilshire Oncology Medical Group Pilot Phase I‐II Study

C. Presant, C. Wiseman, M. Wyres, 1986, American journal of clinical oncology.

Buserelin treatment of advanced prostatic carcinoma long‐term follow‐up of antitumor responses and improved quality of life

C. Presant, C. Wiseman, M. Soloway, 1987, Cancer.

Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.

C. Presant, C. Wiseman, D. Blayney, 1987, Progress in clinical and biological research.

Increased T-helper lymphocytes following active specific intralymphatic immunotherapy of cancer.

C. Presant, C. Wiseman, A. Bakke, 1986, Journal of biological response modifiers.

Stereotactic biopsy and brachytherapy of brain tumours.

P. Dyck, A. Bouzaglou, P. Gruskin, 1987, Neurological research.